Stockscreener 앱 받기
28.10
0.00%
0.00
시간 외 거래:
27.55
-0.55
-1.96%
전일 마감가:
$28.10
열려 있는:
$28.2
하루 거래량:
162.75K
Relative Volume:
0.55
시가총액:
$1.93B
수익:
-
순이익/손실:
$-48.26M
주가수익비율:
-35.57
EPS:
-0.7899
순현금흐름:
$-45.04M
1주 성능:
-6.27%
1개월 성능:
+3.01%
6개월 성능:
+83.78%
1년 성능:
+114.83%
1일 변동 폭
$27.24
$28.60
1주일 범위
$27.24
$30.57
52주 변동 폭
$11.83
$31.44
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
28.10 | 1.97B | 0 | -48.26M | -45.04M | -0.7899 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-06-04 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-03-13 | 개시 | Guggenheim | Buy |
| 2025-03-07 | 개시 | RBC Capital Mkts | Outperform |
| 2025-02-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-16 | 개시 | H.C. Wainwright | Buy |
| 2022-06-16 | 개시 | ROTH Capital | Buy |
모두보기
Gh Research Plc 주식(GHRS)의 최신 뉴스
Net margin % of GH Research Plc – HAM:1KA - TradingView
Net income before discontinued operations of GH Research Plc – HAM:1KA - TradingView
How Rising Losses And Milestone Spending At GH Research (GHRS) Have Changed Its Investment Story - simplywall.st
GHRS Q2 2026 Earnings: Narrower Loss of -$0.23 Per Share Beats Estimates by 25.6%Earnings Trend Analysis - vinanet.vn
Zacks Research Upgrades GH Research (NASDAQ:GHRS) to Hold - MarketBeat
RA Capital discloses 7.1% GH Research PLC (GHRS) stake in Schedule 13G/A - Stock Titan
Lynx1 Capital Management (NASDAQ: GHRS) reports 19.3% stake in GH Research - Stock Titan
GH Research PLC (NASDAQ:GHRS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
GH Research PLC Director Duncan Moore Granted 2,202 Share Options - Kalkine Media
GH Research PLC (GHRS) director receives 2,202 fully vested share options - Stock Titan
GH Research PLC (GHRS) director receives 2,202 options at $0.025 strike - Stock Titan
GH Research PLC (GHRS) grants 102,202 share options to director Michael Forer - Stock Titan
GH Research (NASDAQ:GHRS) Sees Strong Trading VolumeShould You Buy? - MarketBeat
FY2026 EPS Estimates for GH Research Boosted by Analyst - MarketBeat
GH Research (GHRS) Retreats 2.4% to $29.53 as Clinical-Stage Biotech ConsolidatesFibonacci Entry Signals - vinanet.vn
Trading the Move, Not the Narrative: (GHRS) Edition - Stock Traders Daily
H.C. Wainwright reiterates GH Research stock rating on FDA progress By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates GH Research stock rating on FDA progress - Investing.com
Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative? - Sahm
GH Research (NASDAQ:GHRS) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
GH Research (NASDAQ:GHRS) Upgraded at Wall Street Zen - MarketBeat
GH Research stock hits all-time high at 31.41 USD By Investing.com - Investing.com India
GH Research (NASDAQ:GHRS) Reaches New 12-Month High Following Earnings Beat - marketbeat.com
GH Research stock hits all-time high at 31.41 USD - Investing.com
GH Research (NASDAQ:GHRS) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says - MarketBeat
GH Research PLC (GHRS) Stock Analysis: A Biotech Powerhouse with 30.55% Upside Potential - DirectorsTalk Interviews
GH Research PLC (GHRS) Stock News Today - TradingKey
GH Research PLC (GHRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GH Research (GHRS) Dips 1.21% to $30.27 Amid Clinical-Stage Biotech CautionTechnical Analysis Picks - vinanet.vn
GH Research PLC Stock 12‑Month Price Target Raised to $41.1, Implies 41% Upside - TradingView
Needham & Company LLC Raises GH Research (NASDAQ:GHRS) Price Target to $39.00 - MarketBeat
GH Research PLC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GHRS: GH001 achieves rapid, sustained TRD remission with fewer visits and robust IP protection - tradingview.com
GH Research (Nasdaq: GHRS) grows cash to $362.7M as R&D spending rises - Stock Titan
GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
GH Research says H1 loss widens as R&D spending rises on GH001 clinical, technical development work - Bitget
GH Research (NASDAQ:GHRS) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Is GH Research (GHRS) Trading At A Premium To Fair Value? - Yahoo Finance
Is GH Research (GHRS) Fully Valued Following Its Share Price Surge? - Sahm
(GHRS) Volatility Zones as Tactical Triggers - Stock Traders Daily
GHRS Q1 2026 Earnings: Clinical-Stage Biotech Reports Wider-Than-Expected LossRevenue Surprise History - vinanet.vn
GH Research PLC (GHRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GH Research (NASDAQ:GHRS) Raised to Strong-Buy at Wells Fargo & Company - MarketBeat
GHRS|GH Research PLC|Price:27.830|Chg%:+0.550 - TradingKey
GH Research PLC (GHRS) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
GHRS Initiated Coverage by Wells Fargo -- Price Target Announced at $44 - GuruFocus
GH Research PLC (GHRS) Institutional Confidence - TradingKey
Troluce Capital Advisors LLC Raises Holdings in GH Research PLC $GHRS - MarketBeat
GH Research PLC (GHRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GH Research PLC (GHRS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GH Research PLC (GHRS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Gh Research Plc (GHRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
3.22%
자본화:
|
볼륨(24시간):